Udo Bonnet
Essen, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 129 publications
Cannabis-Related Hospitalizations Before and After Partial Legalization: An Analysis From Five Psychiatric Clinics in the Rhine-Ruhr Metropolitan Area.
Journal: Deutsches Arzteblatt international
Published: July 21, 2026
Intravenous Subnarcotic Ketamine Infusions for Treatment-Resistant Depression: Historical Development, Comparison with Esketamine Nasalspray, and Prospects
Journal: Fortschritte der Neurologie-Psychiatrie
Published: June 08, 2026
Attitudes of Patients with Non-Psychotic Mental Disorders Towards Cannabis After Its Legalization-Comparison with Patients Before Legalization.
Journal: Brain sciences
Published: May 07, 2026
The increasing problem of the nonmedical use of medical cannabis
Journal: Der Nervenarzt
Published: April 07, 2026
Cannabis hyperemesis syndrome: the rare case of a valid diagnosis plus hypersensitization hypothesis for development and chronification of this severe somatic cannabis use disorder.
Journal: Fortschritte der Neurologie-Psychiatrie
Published: January 28, 2026
From controversy to clinical evidence: the evolving role of cannabis in pain therapy.
Journal: European archives of psychiatry and clinical neuroscience
Published: November 25, 2025
Cannabinoid Hyperemesis Syndrome: A Scoping Review
Journal: Fortschritte der Neurologie-Psychiatrie
Published: November 12, 2025
Are Intravenous Subnarcotic Ketamine Infusions as an Adjunct Treatment for Treatment-Resistant Depression Ready to be Recommended in European Guidelines?
Journal: Pharmacopsychiatry
Published: August 06, 2025
Not only the main streams, but also the tributaries supply the landscape: antidepressants for the prevention of severe COVID-19.
Journal: European archives of psychiatry and clinical neuroscience
Published: August 03, 2025
The diamorphine treatment of opioid addicts-On the amendment of the indication criteria according to the narcotics prescription regulation
Journal: Der Nervenarzt
Published: July 21, 2025
Zuclopenthixol inhibits residual activity of acid sphingomyelinase in Niemann pick disease type B: a case report with in vitro validation.
Journal: Orphanet journal of rare diseases
Published: July 02, 2025
Last Updated: 09/26/2026